Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Keros Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:KROS | Benzinga

Q: What sector and industry does Keros Therapeutics (KROS) operate in?

Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Keros Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KROS.

Open	-
Close	-
Volume / Avg.	9.13K / 1.45M
Day Range	- - -
52 Wk Range	9.12 - 72.37
Market Cap	$502.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	13.6%
Days to Cover	6.1

Recent News

Deal Dispatch: Harley-Davidson To Wipe Out? Plus, Prada's Versace Purchase Garners A Fashionable Price

Things are hog wild at Harley-Davidson; Plus, Impresoft, Keros Therapeutics and Rivalry Corp. are all itching for a deal.

Anthony Noto

Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan

Keros Therapeutics launches strategic review and adopts rights plan after investor activity signals potential changes in company control.

Vandana Singh

Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	9.13K / 1.45M
Day Range	- - -
52 Wk Range	9.12 - 72.37
Market Cap	$502.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	13.6%
Days to Cover	6.1

About Keros Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, devel...

Got Questions? Ask

How has KROS's EPS changed?

How is the earnings season affecting KROS?

Show KROS's technical analysis

What are analysts' targets for KROS?

What is KROS's free cash flow?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Keros Therapeutics (KROS) stock?

You can purchase shares of Keros Therapeutics (NASDAQ:KROS) through any online brokerage.

View our list of the best stock brokerages

Who are Keros Therapeutics (KROS) competitors?

Other companies in Keros Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Cogent Biosciences (NASDAQ:COGT) and Upstream Bio (NASDAQ:UPB).

What is the forecast, or price target, for Keros Therapeutics (KROS) stock?

Keros Therapeutics has a consensus price target of $30.67.

What is the current price for Keros Therapeutics (KROS)?

The stock price for Keros Therapeutics (NASDAQ: KROS) is $12.4 last updated April 14, 2025 at 8:19 AM EDT.

Does Keros Therapeutics (KROS) pay a dividend?

There are no upcoming dividends for Keros Therapeutics.

When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?

Keros Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Keros Therapeutics (KROS) going to split?

There is no upcoming split for Keros Therapeutics.

What sector and industry does Keros Therapeutics (KROS) operate in?

Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Keros Therapeutics Stock Price, Quotes and Forecasts

Keros Therapeutics (KROS) Forecast